Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view.
In recent years, increasing attention has focused on the need for more research to be conducted in women on health issues directly relevant to women. No one would disagree that the need for such studies is both crucial and timely. However, while the need for more research in women is urgent, the planning and conduct of such studies must always be driven by good science. Specifically, investigations in women may have unique and important scientific and logistic problems which must be recognized and addressed. However, if the trials are well designed and conducted, they will provide a sound and reliable body of data upon which to base rational clinical decision making and public health recommendations for women from women. These general issues are discussed in the context of a particular trial, the Women's Health Study, a randomized trial of the risks and benefits of low-dose aspirin, beta-carotene and vitamin E in the primary prevention of cardiovascular disease and cancer among healthy women.
Buring
J E
JE
Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Hennekens
C H
CH
D001241:Aspirin / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002338:Carotenoids / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014810:Vitamin E / Q000008:administration & dosage; D019207:beta Carotene
D019207:beta Carotene; D014810:Vitamin E; D002338:Carotenoids; D001241:Aspirin